While nothing is set in stone, ESPN reported earlier this week that the UFC has been in contact with Johns Hopkins University, “with an eye toward seeing if the drugs can be helpful for fighters dealing with brain issues.”
Four particular psychedelics have been the subject of most of the recent psychiatric research and have been or are being investigated in terms of eating disorders—Ketamine, MDMA, Psilocybin, and Ayahuasca.
Mona Strelaeff, a 67 year-old woman living in Victoria, B.C., said she was granted an exemption to the Controlled Drugs and Substances Act allowing her to consume shrooms to treat ongoing trauma.
And amid the growing buzz around psychedelics, there’s been an exponential explosion in research into LSD, psilocybin, MDMA and ketamine to treat conditions such as depression, post-traumatic stress disorder (PTSD), anxiety and substance-use …
A Vancouver-based psychedelics company has become the first in Canada to complete a legal harvest of magic mushrooms since the last wave of psychedelic research ended there in the 1970s.
Four Canadian cancer patients have been granted permission to use psilocybin as a treatment for end-of-life distress, a groundbreaking role for the hallucinogen in health care.
Get access to our local price list
No trace, no invoice transaction
Discrete and anonymous delivery
We get it, your inbox is busy. That's why we promise to only share quality content. Once per month we carefully craft a thoughtful newsletter featuring new seasonal products, promotions, team update and industry news. Sign up today!
